Propanc Biopharma Earnings
NASDAQ: PPCBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.78+0.055 (+3.19%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Propanc Biopharma earnings summary
In its most recent report on Nov 13, 2026 (Sep/2026), PPCB posted EPS of $-12.22.
Summary generated from market data by MetaCap's automated system. Methodology
PPCB earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 13, 2026 | — | $-12.22 | — | -8.3% |
| Sep 25, 2026 | — | $81.04 | — | — |
| May 14, 2026 | — | $-0.28 | — | — |
| Feb 17, 2026 | — | $-0.30 | — | — |
| Nov 14, 2025 | — | $-98.08 | — | — |
| Sep 29, 2025 | — | $-290.52 | — | — |
| May 15, 2025 | — | $-12.50 | — | — |
| Feb 14, 2025 | — | $-32.23 | — | — |
| Nov 14, 2024 | — | $-35.97 | — | — |
| Sep 30, 2024 | — | $684.85 | — | — |
| May 15, 2024 | — | $-545.79 | — | — |
| Feb 20, 2024 | — | $-1,559.55 | — | — |
| Nov 14, 2023 | — | $-0.04 | — | — |
| Sep 28, 2023 | — | $1.28 | — | — |
| May 15, 2023 | — | $-0.42 | — | — |
| Feb 10, 2023 | — | $-0.53 | — | — |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.